AzTrials
AzTrials

Consensus DevelopmentNCT04471103

Comparison of Multi-Round and Real-Time Delphi Survey Methods

A study testing Participation in a Delphi survey in people with Consensus Development, run by National University of Ireland, Galway, Ireland at 1 site in Ireland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A two-group parallel randomised trial of Delphi survey methods. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Consensus Development
What is being tested?
Participation in a Delphi survey
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
1 siteIreland
Study dates
13 Aug 2021to 7 Feb 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • parents or caregivers of infants that have been diagnosed with and received treatment for neonatal encephalopathy
  • healthcare providers including:
  • neonatal nurse practitioners
  • midwives
  • obstetricians
  • neonatologists/paediatricians
Show all 10Show fewer
  • neonatal/paediatric neurologists
  • general practitioners who provide long-term care for children with neonatal encephalopathy
  • policymakers
  • researchers/ academics with expertise in neonatal encephalopathy treatment.

Who cannot join

  • participants not meeting the inclusion criteria

Trial locations and contacts

1 site in 1 country.

Fiona A Quirke, BSc contact

+353 91 495 481

f.quirke1@nuigalway.ie

Ireland1 site, 1 recruiting
  • HRB-TMRN

    Galway, H91 W6P8

    Declan M Devane, PhD, 091 49 5828, declan.devane@nuigalway.ie

    Sandra Galvin, PhD, 091 494493, sandra.galvin@nuigalway.ie

    Recruiting

Other trials in Ireland

About this study

Official title: Multi-round Compared to Real-Time Delphi for Consensus in Core Outcome Set (COS) Development: A Randomised Trial

A two-group parallel randomised trial of Delphi survey methods.

Read the detailed description

Aim:

The aim of this trial is to compare a multi-round Delphi survey method with a Real-Time Delphi method on prioritised outcomes included in a core outcome set (COS). This trial is embedded within the COHESION study which is developing a COS for interventions for the treatment of neonatal encephalopathy.

Methods:

Stakeholders (parents/ caregivers of infants diagnosed and treated with neonatal encephalopathy, healthcare providers and researchers) will be randomised using stratified randomisation to take part in either a multi-round or Real-Time Delphi. Stakeholders will rate the importance of the same set of outcomes in both arms. We will compare the prioritised outcomes at the end of both surveys as well as other parameters such as feedback, initial condition and iteration effects.

Being tested
Participation in a Delphi survey
Keywords
Delphi, Real-Time Delphi, Multi-Round Delphi, Randomised Trial, Two-Group Parallel, Survey

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Participation in a Delphi surveyOther

    Participants will be asked to participate in an online Delphi survey (using one of two randomly allocated methods) to rate the importance of outcomes that should be measured to determine the effect of treatment for neonatal encephalopathy. Outcomes will be prioritised on their importance in a consensus-driven manner.

Study groups in NCT04471103
Study groupRoleWhat they receive
Real-Time Delphi MethodExperimentalThe Real-Time Delphi Method involves a single-round Delphi survey rating the importance of outcomes for neonatal encephalopathy. Feedback on each outcome (participant's own rating score, rating of the outcome by stakeholder group and overall consensus results for that outcome) will be provided to the participant once they have rated an outcome. They can then modify how they rated the outcome based on this feedback if they wish. Participants can also re-visit and re-rate outcomes as many times as they wish when the survey is live. Duration will span approximately 5 weeks.
Receives: Other: Participation in a Delphi survey
Multi-round Delphi MethodActive comparatorThe Multi-Round Delphi Method involves a three-round Delphi survey rating the importance of outcomes for neonatal encephalopathy. Feedback on each outcome (participant's own rating score, rating of the outcome by stakeholder group and overall consensus results for that outcome) will be provided to the participant at the end of Round 1 and the end of Round 2. Participants can then modify how they rated the outcome based on feedback, in Rounds 2 and 3, if they wish. Each survey Round will run for 3 weeks approximately. In between survey Rounds, there will be a downtime of approximately 10 days before providing feedback and a further 7 days before starting the next round. Duration will span approximately 14 weeks.
Receives: Other: Participation in a Delphi survey

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of outcomes prioritised within each survey arm

    Comparison of outcomes prioritised by respondents at the end of (i) the Real-time and (ii) multi-round Delphi processes. An outcome is judged 'prioritised' based on the proportion of respondents rating the outcome a 7-9 (inclusive) on a 9-point Likert scale (higher scores = higher importance for inclusion in the COS)

    Measured: End of both surveys (i.e. when the Multi-Round Delphi round 3 has finished and when the Real-Time Delphi has finished at the end of week 5).

Secondary outcomes (4)
  1. Feedback Effect

    The feedback effect will tell if the feedback provided to participants resulted in them amending the rating they have to each outcome on the 9-point scale (higher scores= higher importance for inclusion in the COS)

    Measured: Through study completion, an average of 14 weeks.

  2. Initial Condition Effect

    The initial condition effect will capture if early participant's rating for each outcome on the 9-point scale ( higher scores= higher importance for inclusion in the COS) differs to rating given by later participants.

    Measured: During the Real-Time Delphi intervention (5 weeks).

  3. Iteration Effect

    The iteration effect will determine if there is a difference in how consensus is achieved on prioritising each outcome or not, between the Multi-Round and the Real-Time Delphi survey arms

    Measured: Through study completion, an average of 14 weeks.

  4. Comparison of outcomes prioritised within each survey arm with the final Core Outcome Set

    Comparison of the of outcome headings prioritised at the end of both the Real-Time and Multi-Round Delphi processes with the outcome headings in the final Core Outcome Set.

    Measured: Through study completion, an average of 1 year.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jul 2020
  2. Study start13 Aug 2021
  3. Primary completion7 Feb 2022 (estimated)
  4. Study completion7 Feb 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
A two-group parallel randomised trial
Masking
None (open label)
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04471103
Sponsor's protocol ID
NUIreland-COHESION
Status last verified
Sep 2021
First submitted
2 Jul 2020
Last updated
2 Sep 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Quirke FA, Battin MR, Bernard C, Biesty L, Bloomfield FH, Daly M, Finucane E, Haas DM, Healy P, Hurley T, Koskei S, Meher S, Molloy EJ, Niaz M, Bhraonain EN, Okaronon CO, Tabassum F, Walker K, Webbe JRH, Parkes MJ, Kirkham JJ, Devane D. Multi-Round versus Real-Time Delphi survey approach for achieving consensus in the COHESION core outcome set: a randomised trial. Trials. 2023 Jul 19;24(1):461. doi: 10.1186/s13063-023-07388-9.

    PubMed 37468987
  • Quirke FA, Healy P, Bhraonain EN, Daly M, Biesty L, Hurley T, Walker K, Meher S, Haas DM, Bloomfield FH, Kirkham JJ, Molloy EJ, Devane D. Multi-Round compared to Real-Time Delphi for consensus in core outcome set (COS) development: a randomised trial. Trials. 2021 Feb 15;22(1):142. doi: 10.1186/s13063-021-05074-2.

    PubMed 33588938

Questions about this trial

What is this clinical trial studying?

A study testing Participation in a Delphi survey in people with Consensus Development, run by National University of Ireland, Galway, Ireland at 1 site in Ireland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Fiona A Quirke, BSc (+353 91 495 481, f.quirke1@nuigalway.ie), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of outcomes prioritised within each survey arm (time frame: End of both surveys (i.e. when the Multi-Round Delphi round 3 has finished and when the Real-Time Delphi has finished at the end of week 5).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04471103, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Sep 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in